ASCENT INDUSTRIES CORP Stock Canadian Securities Exchange
Stocks
LUFF
CA04365B1067
Pharmaceuticals
OTC Markets Traded|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0200 CAD | -20.00% |
|
+25.00% | +66.67% |
| 06-16 | Herbal Dispatch Expands Domestic Retail Operations And Proprietary Brand Portfolio | CI |
| 06-09 | Herbal Dispatch Completes a 45-Kilorgram Multi-Client Medical Cannabis Export Shipment To Europe | MT |
| Market Cap | 6.17M 4.34M 3.8M 3.49M 3.25M 413M 6.26M 41.88M 16.28M 203M 16.3M 15.95M 700M | P/E 2024 |
-1.85x | P/E 2025 | -3.69x |
|---|---|---|---|---|---|
| Enterprise Value | 7.67M 5.4M 4.72M 4.34M 4.05M 514M 7.79M 52.1M 20.25M 253M 20.28M 19.84M 871M | EV / Sales 2024 |
0.67x | EV / Sales 2025 | 0.89x |
| Free-Float |
85.39% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -20.00% |
| Manager | Title | Age | Since |
|---|---|---|---|
Philip Campbell
CEO | Chief Executive Officer | - | 2020-05-14 |
Jason Vandenberg
DFI | Director of Finance/CFO | 49 | 2022-01-17 |
Aron Tegenfeldt
PRN | Corporate Officer/Principal | - | 2022-07-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Herb Dhaliwal
CHM | Chairman | 73 | 2026-04-22 |
Philip Campbell
BRD | Director/Board Member | - | 2020-05-14 |
Drew Malcolm
BRD | Director/Board Member | - | 2020-06-23 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -20.00% | +25.00% | - | - | 4.34M | |
| +0.21% | +3.96% | -12.47% | -7.71% | 12.84B | |
| +0.34% | +4.33% | -34.57% | -57.93% | 4.72B | |
| +2.23% | +12.59% | +17.91% | -6.37% | 3.91B | |
| +1.10% | +6.55% | +4.13% | -39.43% | 3.84B | |
| +0.13% | -11.54% | -14.01% | -20.23% | 3.05B | |
| +1.74% | +5.74% | -11.17% | -1.48% | 3.08B | |
| +0.79% | +6.47% | -7.22% | -25.40% | 2.38B | |
| +0.53% | +7.02% | -14.09% | +33.06% | 1.72B | |
| +2.59% | +8.49% | -11.64% | -14.77% | 1.69B | |
| Average | -1.03% | +0.24% | -9.23% | -15.58% | 4.14B | |
| Weighted average by Cap. | +0.81% | +0.14% | -10.09% | -17.29% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 9.92M 6.99M 6.11M 5.61M 5.23M 665M 10.07M 67.38M 26.2M 327M 26.22M 25.66M 1.13B | 12.12M 8.54M 7.46M 6.86M 6.39M 813M 12.31M 82.33M 32M 400M 32.04M 31.35M 1.38B |
| Net income | -2.77M -1.95M -1.71M -1.57M -1.46M -186M -2.82M -18.83M -7.32M -91.38M -7.33M -7.17M -315M | -1.84M -1.3M -1.13M -1.04M -971K -123M -1.87M -12.5M -4.86M -60.68M -4.87M -4.76M -209M |
| Net Debt | 1.37M 968K 846K 778K 725K 92.17M 1.4M 9.34M 3.63M 45.3M 3.63M 3.56M 156M | 1.51M 1.06M 927K 852K 794K 101M 1.53M 10.22M 3.97M 49.61M 3.98M 3.89M 171M |
Employees
-
Sector
Pharmaceuticals
- Stock Market
- Stocks
- HERB Stock
- LUFF Stock
Select your edition
All financial news and data tailored to specific country editions
